# NT-proBNP Levels During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.

> **NCT06317428** · — · UNKNOWN · sponsor: **Istituto Nazionale di Ricovero e Cura per Anziani** · enrollment: 29 (estimated)

## Conditions studied

- COPD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06317428
- **Lead sponsor:** Istituto Nazionale di Ricovero e Cura per Anziani
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-28
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2024-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06317428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06317428, "NT-proBNP Levels During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06317428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*